🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pierre‐Luc Boudreault

Université de Sherbrooke

ORCID: 0000-0002-2032-7970

Also affiliated with Service de la Santé Publique, Université des Sciences de la Santé, Institut de pharmacologie de Sherbrooke

Materials ScienceEngineeringBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice”.

A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.03.442520
N/A
0DataRank · unranked
17 citations

I. Abrrey Monreal, Sébastien P. Dion, Mason Jager, Antoine Désilets, Andrea D. Olmstead +18 more

A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic

Nature(2022)10.1038/s41586-022-04661-w
N/A
0DataRank · unranked
233 citations

I. Abrrey Monreal, Sébastien P. Dion, David W. Buchholz, Brian Imbiakha, Andrea D. Olmstead +21 more

A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants

Emerging Microbes & Infections(2023)10.1080/22221751.2023.2246594
N/A
0DataRank · unranked
18 citations

L.J. Worrall, Andrea D. Olmstead, Anh‐Tien Ton, Jaeyong Lee, Ivan Villanueva +25 more

Corrigendum to “Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics” “Antiviral Research 209 (2023)/105484”

Antiviral Research(2023)10.1016/j.antiviral.2023.105577
N/A
0DataRank · unranked
0 citations

Tirosh Shapira, Andrea D. Olmstead, Iván Villanueva, Connor A.H. Thompson, Siobhan Ennis +40 more

The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response

Oncotarget(2024)10.18632/oncotarget.28585
N/A
0DataRank · unranked
5 citations

Johanne Toutant, Aurélie Delannoy, David Durantel, Anna Salvetti, Sophie Ehresmann +11 more

Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.08.28.609965
N/A
0DataRank · unranked
1 citations

Antoine Désilets, William Champagne, Malihe Hassanzadeh, Gabriel Lemieux, Alice Gravel-Trudeau +7 more

Structural basis of TMPRSS11D specificity and autocleavage activation

Nature Communications(2025)10.1038/s41467-025-59677-3
N/A
0DataRank · unranked
6 citations

Ryan P. Wilson, Sára Ferková, Olzhas Ilyassov, Jackie Lac, Aiping Dong +13 more